Hartaj Singh

Hartaj Singh is Managing Director and Senior Analyst covering Biotechnology. Prior to joining Oppenheimer, Hartaj was Managing Director and Senior Biotechnology Analyst at BTIG Securities. Hartaj began his sell – side career at Lehman Brothers and subsequently moved to the buyside covering Biotechnology at Visium Asset Management and Tecumseh Partners. He began his career as a Clinical Trial Project Manager for ClinTrials Research and also worked as a Strategic Analysis Manager for Johnson & Johnson, both of which give h im critical experience in clinical trial design. Hartaj has a B.A. in Biology from Case Western Reserve University and also did extensive graduate work in Computational Neurobiology. He also holds an M.B.A. from Duke University’s Fuqua School of Business